grant

Stress Hormone Regulation of HSV1 and HSV2 in Autonomic and Sensory Neurons

Organization VIRGINIA POLYTECHNIC INST AND ST UNIVLocation BLACKSBURG, UNITED STATESPosted 21 Sept 2022Deadline 31 Aug 2027
NIHUS FederalResearch GrantFY202521+ years old3'5'-cyclic ester of AMPAcute DiseaseAdenosine Cyclic 3',5'-MonophosphateAdenosine Cyclic MonophosphateAdenosine, cyclic 3',5'-(hydrogen phosphate)AdrenalineAdrenergic ReceptorAdrenoceptorsAdultAdult HumanAeroseb-HCAfferent NeuronsAldosterone ReceptorAnimal ModelAnimal Models and Related StudiesAnti-viral AgentsAutonomic PathwaysAutonomic nervous systemBlindnessBrain InflammationC-jun Amino-Terminal KinaseC-jun Kinase-1C-jun N-Terminal Kinase 1CREBCREB1CREB1 geneCaviaCetacortChromatinCort-DomeCortefCortenemaCorticosteroneCortisolCortisprayCortrilCyclic AMPDataDermacortDevelopmentDorsal Root GangliaEldecortEncephalitisEndocrine Gland SecretionEpinephrineEpinephrine ReceptorsEventFaceFrequenciesG-Protein alpha SubunitG-Protein α SubunitGTP-Binding Protein alpha SubunitsGTP-Binding Protein α SubunitsGasser's GanglionGasserian GanglionGenital OrgansGenitaliaGlucocorticoid ReceptorGoalsGuinea PigsGuinea Pigs MammalsHHV-2HHV2HSVHSV-1HSV-2HSV1HSV2Herpes Simplex Type 1Herpes Simplex VirusHerpes Simplex Virus 1Herpes Simplex Virus 2Herpes Simplex Virus Type 1Herpes Simplex Virus Type 2Herpes labialis VirusHerpesvirus 1Herpesvirus 2 (alpha), HumanHerpesvirus progenitalisHormonesHuman (alpha) herpes virus 2Human Herpesvirus 2Human herpes simplex virus type 2HydrocortisoneHydrocortoneHytoneIFNInfectionInterferonsJN KinaseJNKJNK Mitogen-Activated Protein KinasesJNK1JNK1 KinaseJNK1 proteinJNK1A2JNK21B1/2LifeMAP Kinase 8MAP Kinase 8 GeneMAPK8MAPK8 Mitogen-Activated Protein KinaseMAPK8 geneMaintenanceMediatingMeningitisMineralocorticoid ReceptorMitogen-Activated Protein Kinase 8ModelingNerve CellsNerve UnitNeural CellNeurocyteNeuronsNutracortOrganPRKM8PathogenesisPathway interactionsPatternPelvicPelvic RegionPelvisProcessProctocortReceptor ProteinRecurrenceRecurrentRecurrent diseaseRelapsed DiseaseResearchRodentRodentiaRodents MammalsSAP Kinase-1SAPK/JNKSAPK1 Mitogen-Activated Protein KinaseSAPK1/JNKSemilunar GanglionSensorySensory NeuronsSeveritiesSignal PathwaySignaling Factor Proto-OncogeneSignaling Pathway GeneSignaling ProteinSimplexvirusSourceSpinal GangliaStimulusStressStress-Activated Protein Kinase JNK1Stress-Activated Protein Kinase gammaStructure of trigeminal ganglionSymptomsTherapeutic EpinephrineTherapeutic HormoneTranscription InitiationTransmissionTrigeminal GangliasTrigeminal GanglionTrigeminal SystemVP 16VP16Viral DiseasesViral LatencyVirusVirus ActivationVirus DiseasesVirus InductionVirus LatencyWorkacute disease/disorderacute disorderadenoreceptoradenosine 3'5' monophosphateadulthoodanti-viral compoundanti-viral developmentanti-viral drug developmentanti-viral drugsanti-viral medicationanti-viral therapeuticanti-viral therapeutic developmentanti-viral therapy developmentanti-viralsantiviral developmentantiviral drug developmentantiviral therapeutic developmentantiviral therapy developmentc-jun N-Terminal KinasecAMPcAMP Response Element-Binding Protein 1cutaneous lesionsdermal lesiondeveloping anti-viral agentdeveloping anti-viral drugdeveloping anti-viral therapeuticdeveloping anti-viral therapydeveloping antiviral agentdeveloping antiviral drugdeveloping antiviral therapeuticdeveloping antiviral therapydevelopmentaldorsal root ganglionexperimentexperimental researchexperimental studyexperimentsfacesfacialherpes simplex iherpes simplex iiherpes simplex-1hormonal regulationhormone regulationhuman alphaherpesvirus 2human modelin vivoinnovateinnovationinnovativejun-NH2-Terminal Kinasemodel of animalmodel of humanneuronalpathwaypreventpreventingreceptorresponseskin lesionstress-activated protein kinase 1transmission processtrigeminalviral DNAviral activationviral inductionviral infectionvirus DNAvirus infectionvirus-induced diseasevision lossvisual loss
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Stress Hormone Regulation of HSV1 and HSV2 in Autonomic and Sensory Neurons
Abstract

HSV1 and HSV2 recurrences typically result in skin lesions but may also cause blindness, sacral meningitis, or

life-threatening encephalitis. Stress is known to be one of the primary triggers for HSV recurrent disease, although

surprisingly little is known about how it does so. Although most studies have focused on viral latency in sensory

neurons of either the trigeminal ganglia or lumbosacral dorsal root ganglia, HSV also establishes latency in

autonomic neurons, which innervate the face and genitals very differently, are highly responsive to known

reactivation stimuli, and likely contribute to differential pathogenesis of HSV1 and HSV2. Our preliminary studies

demonstrate that the sympathetic pathways, which are one branch of the autonomic nervous system, have a

significant impact on the severity of HSV1 acute disease symptoms and contribute to 74% of HSV1 and 49% of

HSV2 recurrences in vivo. Stress hormones, regulated by the autonomic nervous system, modulate different

types of neurons through glucocorticoid and adrenergic receptors, which are expressed in different patterns on

sensory and autonomic neurons in which HSV1 and HSV2 establish latency. The short-term stress hormone

epinephrine induces HSV1 reactivation, but not HSV2, and this only occurs in sympathetic neurons. In contrast,

corticosterone (the rodent form of cortisol, the long-term stress hormone) induces reactivation of both HSV1 and

HSV2. However, corticosterone cause HSV1 to reactivate only in sympathetic neurons, but causes HSV2 to

reactivate in both sympathetic and sensory neurons. We have identified the receptors through which epinephrine

and corticosterone induce reactivation and have substantial preliminary data suggesting specific signaling

pathways and proteins that are involved in the process of reactivation. The central hypothesis of this proposal

is that stress hormones selectively regulate HSV1 and HSV2 infections in autonomic neurons, leading to

differential reactivation and recurrence frequencies of HSV1 and HSV2. Using primary adult neuronal cultures

and the guinea pig infection model, we will 1) identify the signaling pathways through which epinephrine

selectively induces HSV1 reactivation from primary adult sympathetic neurons, and 2) identify the signaling

pathways through which corticosterone (CORT) selectively induces HSV1 and HSV2 reactivation from primary

adult sensory and sympathetic neurons. The proposed research is expected to challenge the paradigm of HSV

reactivation by demonstrating that maintenance of latency and the process of reactivation are not “one size fits all,”

and that autonomic neurons are an important source of HSV recurrent disease. Our studies will show that different

mechanisms cause reactivation of HSV1 and HSV2 in different types of neurons. The work also has far-reaching

implications for understanding how sensory and autonomic neurons differentially respond to viral infections, in

general.

Grant Number: 5R01NS129820-04
NIH Institute/Center: NIH

Principal Investigator: Andrea Bertke

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →